Review
Chinese medicines for prevention and treatment of human hepatocellular carcinoma: current progress on pharmacological actions and mechanisms

https://doi.org/10.1016/S2095-4964(15)60171-6Get rights and content

Abstract

Hepatocellular carcinoma (HCC) is one of leading causes of death in the world. Although various treatments have been developed, the therapeutic side effects are far from desirable. Chinese medicines (CMs, including plants, animal parts and minerals) have drawn a great deal of attention in recent years for their potential in the treatment of HCC. Most studies have shown that CMs may be able to retard HCC progression with multiple actions, either alone or in combination with other conventional therapies to improve quality of life in HCC patients. Additionally, CMs are used for preventing HCC occurrence. The aim of this study is to review the potential prophylactic and curative effects of CMs on human HCC and the possible mechanisms that underlie these pharmacological actions. Publications were collected and reviewed from PubMed and China National Knowledge Infrastructure from 2000 to 2014. Keywords for literature searches include ā€œChinese medicineā€, ā€œChinese herbā€, ā€œtraditional Chinese Medicineā€, ā€œhepatocellular carcinomaā€ and ā€œliver cancerā€. CMs in forms of pure compounds, isolated fractions, and composite formulas are included. Combination therapies are also considered. Both in vitro and in vivo efficacies of CMs are being discussed and the translational potential to bedside is to be discussed with clinical cases, which show the actions of CMs on HCC may include tumor growth inhibition, antimetastatic activities, anti-inflammation, anti-liver cancer stem cells, reversal on multi-drug resistance and induction/reduction of oxidative stress. Multiple types of molecules are found to contribute in the above actions. The review paper indicated that CMs might have potential to both prevent HCC occurrence and retard HCC progression with several molecular targets involved.

References (217)

  • L Lou et al.

    Ardipusilloside inhibits survival, invasion and metastasis of human hepatocellular carcinoma cells

    Phytomedicine

    (2012)
  • T Eichhorn et al.

    P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs

    J Ethnopharmacol

    (2012)
  • CY Yang et al.

    Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats

    Food Chem Toxicol

    (2006)
  • K Reyes-Gordillo et al.

    Curcumin protects against acute liver damage in the rat by inhibiting NF-ĪŗB, proinflammatory cytokines production and oxidative stress

    Biochim Biophys Acta

    (2007)
  • QL Guo et al.

    Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells

    Life Sci

    (2006)
  • Y Yang et al.

    Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes

    Cancer Lett

    (2007)
  • Y Hu et al.

    Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity

    Biochem Biophys Res Commun

    (2006)
  • G Song et al.

    Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells

    Colloids Surf B Biointerfaces

    (2006)
  • J Tang et al.

    Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations

    J Ethnopharmacol

    (2009)
  • Z Cheng et al.

    Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells

    Phytomedicine

    (2010)
  • J Yu et al.

    Protective effects of tetrahydropalmatine against Ī³-radiation induced damage to human endothelial cells

    Life Sci

    (2010)
  • D Hu et al.

    Effects of amino acids from selenium-rich silkworm pupas on human hepatoma cells

    Life Sci

    (2005)
  • EF Fang et al.

    The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo

    Cancer Lett

    (2012)
  • A Jemal et al.

    Global cancer statistics

    Ca Cancer J Clin

    (2011)
  • CY Pu et al.

    The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment

    Eur J Cancer Care (Engl)

    (2008)
  • YH Lin et al.

    Use of Chinese medicine among patients with liver cancer in Taiwan

    J Altern Complem Med

    (2010)
  • B Carmady et al.

    Use of Chinese medicine by cancer patients: a review of surveys

    Chin Med

    (2011)
  • LC Wong et al.

    Complementary and alternative medicine practices among Asian radiotherapy patients

    Asia Pac J Clin Oncol

    (2010)
  • M Pan et al.

    Review and expectation of experiments and clinical study in primary liver cancer

    Hunan Zhong Yi Za Zhi

    (2002)
  • Y Liu et al.

    An analysis on the international competitiveness of China's traditional medicine industry based on the SWOT model

    Int J Bus Man

    (2010)
  • J Hou et al.

    Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action

    Clin Cancer Res

    (2008)
  • W Chaijaroenkul et al.

    Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines

    Asia Pac J Cancer Prev

    (2011)
  • WQ Wang et al.

    Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization

    J Hematol Oncol

    (2012)
  • X Yuxian et al.

    Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo

    Tumori

    (2009)
  • SY Chien et al.

    Tanshinone II-A inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo

    Mol Med Report

    (2012)
  • ZK Dai et al.

    Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells

    J Nat Med

    (2012)
  • JM Luk et al.

    Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation

    Liver Int

    (2007)
  • BE Wang

    Treatment of chronic liver diseases with traditional Chinese medicine

    J Gastroenterol Hepatol

    (2000)
  • VK Wong et al.

    Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo

    Clin Cancer Res

    (2005)
  • WY Wu et al.

    Mechanisms of pseudolaric acid B-induced apoptosis in Bel-7402 cell lines

    Am J Chin Med

    (2006)
  • BJ Chen

    Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F

    Leuk Lymphoma

    (2001)
  • EW Chan et al.

    Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines

    Toxicol Lett

    (2001)
  • G Chen et al.

    Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells

    Int J Oncol

    (2012)
  • C Duan et al.

    Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin

    Biomacromolecules

    (2011)
  • SS Dang et al.

    Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV

    World J Gastroenterol

    (2009)
  • XL Zeng et al.

    Induction of differentiation by ginsenoside Rh2 in hepatocarcinoma cell SMMC-7721

    Ai Zheng

    (2004)
  • XL Zeng et al.

    Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721

    Ai Zheng

    (2004)
  • C Rui-Chuan et al.

    Induction of differentiation in human hepatocarcinoma cells by isoverbascoside

    Planta Med

    (2002)
  • RKY Lee et al.

    Polyphyllin D ā€” A potential anti-cancer agent to kill hepatocarcinoma cells with multi-drug resistance

    Current Chemic Biol

    (2009)
  • QF Wang et al.

    Gypenosides induce apoptosis in human hepatoma Huh-7 cells through a calcium/reactive oxygen species-dependent mitochondrial pathway

    Planta Med

    (2007)

    • Cited by (0)

    View full text
    Copyright Ā© 2015 Journal of Integrative Medicine Editorial Office. E-edition published by Elsevier (Singapore) Pte Ltd. All rights reserved. Published by Elsevier B.V. All rights reserved.